Exploring the PI3Kα and γ binding sites with 2,6-disubstituted isonicotinic derivatives
- 15 April 2009
- journal article
- research article
- Published by Elsevier BV in Bioorganic & Medicinal Chemistry Letters
- Vol. 19 (8), 2215-2219
- https://doi.org/10.1016/j.bmcl.2009.02.115
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Targeted polypharmacology: discovery of dual inhibitors of tyrosine and phosphoinositide kinasesNature Chemical Biology, 2008
- Identification and characterization of NVP-BEZ235, a new orally available dual phosphatidylinositol 3-kinase/mammalian target of rapamycin inhibitor with potent in vivo antitumor activityMolecular Cancer Therapeutics, 2008
- The Structure of a Human p110α/p85α Complex Elucidates the Effects of Oncogenic PI3Kα MutationsScience, 2007
- A Pharmacological Map of the PI3-K Family Defines a Role for p110α in Insulin SignalingCell, 2006
- Making optimal use of empirical energy functions: Force‐field parameterization in crystal spaceProteins-Structure Function and Bioinformatics, 2004
- High Frequency of Mutations of the PIK3CA Gene in Human CancersScience, 2004
- Synthesis and Function of 3-Phosphorylated Inositol LipidsAnnual Review of Biochemistry, 2001
- An Efficient Method for the Preparation of Benzylic BromidesSynthesis, 2001
- Structural Determinants of Phosphoinositide 3-Kinase Inhibition by Wortmannin, LY294002, Quercetin, Myricetin, and StaurosporineMolecular Cell, 2000
- PHOSPHOINOSITIDE KINASESAnnual Review of Biochemistry, 1998